Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas
- PMID: 35490384
- PMCID: PMC9543204
- DOI: 10.1111/jdv.18190
Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas
Abstract
Background: Neurofibromatosis type 2 (NF2) is a genetic disease characterized by the appearance of multiple tumours in the nervous system. Cutaneous lesions are common and may provide useful diagnostic and prognostic information, but they have not been widely studied.
Objectives: To characterize cutaneous lesions in a Spanish cohort of patients with NF2 and investigate associations with clinical and genetic severity.
Methods: We studied the clinical and histologic characteristics of cutaneous lesions in 49 patients with NF2 and analysed correlations with phenotype- and genotype-based severity scores. We collected information on the presence/absence of cutaneous lesions, location, age at onset, type of lesion, and histologic features. We also studied level of systemic involvement and genetic mutations involved.
Results: Forty-nine patients (31 women [63.3%] and 18 men [36.7%]) were analysed, and 33 (67.3%) had cutaneous lesions presumed to be schwannomas. According to their clinical form, they were distributed as follows: 24 patients (48%) had deep tumours, 21 (42%) had plaque-like lesions, and 3 (6%) had superficial tumours. Histologic examination from 27 lesions analysed out 23 patients showed classic schwannoma or hybrid schwannoma-neurofibroma features in the 8 deep tumours biopsied and plexiform schwannoma features in the 17 plaque-like lesions and the 2 superficial tumours analysed. Early onset (first 2 decades of life) was reported by all patients with plaques and superficial tumours. In our cohort, 100% of the patients with plaque-like lesions and superficial tumours with microscopic features of plexiform schwannoma were in the 2 groups with the most severe clinical phenotypes, and 82.6% of them were in the 3 most severe genotype-based classes.
Conclusions and relevance: Cutaneous lesions, specially plexiform schwannomas, are common in NF2, and they usually appear at an early age providing useful diagnostic and prognostic information. These tumours are part of the spectrum of cutaneous manifestations in this disease. Although its diagnostic and prognostic value has been pointed out, there are few studies focussed on their analysis.
© 2022 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Figures

Similar articles
-
Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in Childhood.JAMA Dermatol. 2018 Mar 1;154(3):341-346. doi: 10.1001/jamadermatol.2017.5464. JAMA Dermatol. 2018. PMID: 29322178 Free PMC article.
-
Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.J Neurosurg Spine. 2016 Jan;24(1):145-54. doi: 10.3171/2015.3.SPINE141145. Epub 2015 Sep 25. J Neurosurg Spine. 2016. PMID: 26407091
-
Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis?Br J Dermatol. 2003 Apr;148(4):804-9. doi: 10.1046/j.1365-2133.2003.05249.x. Br J Dermatol. 2003. PMID: 12752143
-
Diagnostic and Prognostic Relevance of the Cutaneous Manifestations of Neurofibromatosis Type 2.Actas Dermosifiliogr. 2017 Sep;108(7):630-636. doi: 10.1016/j.ad.2016.12.007. Epub 2017 Feb 22. Actas Dermosifiliogr. 2017. PMID: 28237041 Review. English, Spanish.
-
Gastric plexiform schwannoma in association with neurofibromatosis type 2.Clin J Gastroenterol. 2016 Dec;9(6):352-357. doi: 10.1007/s12328-016-0687-y. Epub 2016 Sep 30. Clin J Gastroenterol. 2016. PMID: 27696205 Review.
References
-
- Selvanathan SK, Shenton A, Ferner R et al. Further genotype‐phenotype correlations in neurofibromatosis 2. Clin Genet 2010; 77: 163. - PubMed
-
- Smith MJ, Higgs JE, Bowers NL et al. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset. J Med Genet 2011; 48: 261–265. - PubMed
-
- Hexter A, Jones A, Joe H et al. Clinical and molecular predictors of mortality in neurofibromatosis 2: a UKnational analysis of 1192 patients. J Med Genet 2015; 52: 699–705. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous